Elisabeth Mocaër

5.7k total citations
125 papers, 4.7k citations indexed

About

Elisabeth Mocaër is a scholar working on Cellular and Molecular Neuroscience, Endocrine and Autonomic Systems and Behavioral Neuroscience. According to data from OpenAlex, Elisabeth Mocaër has authored 125 papers receiving a total of 4.7k indexed citations (citations by other indexed papers that have themselves been cited), including 54 papers in Cellular and Molecular Neuroscience, 46 papers in Endocrine and Autonomic Systems and 41 papers in Behavioral Neuroscience. Recurrent topics in Elisabeth Mocaër's work include Circadian rhythm and melatonin (46 papers), Stress Responses and Cortisol (41 papers) and Neuroscience and Neuropharmacology Research (32 papers). Elisabeth Mocaër is often cited by papers focused on Circadian rhythm and melatonin (46 papers), Stress Responses and Cortisol (41 papers) and Neuroscience and Neuropharmacology Research (32 papers). Elisabeth Mocaër collaborates with scholars based in France, United States and Italy. Elisabeth Mocaër's co-authors include C. Gabriel, Mark J. Millan, Béatrice Guardiola‐Lemaître, Carmen Muñoz, Christian de Bodinat, Pierre‐Alain Boyer, Pierre Renard, Roger D. Porsolt, Michel Bourin and Mariusz Papp and has published in prestigious journals such as Journal of Neuroscience, Nature Reviews Drug Discovery and Scientific Reports.

In The Last Decade

Elisabeth Mocaër

120 papers receiving 4.6k citations

Peers

Elisabeth Mocaër
Angelos Halaris United States
Mark D. Underwood United States
Karim A. Alkadhi United States
Garth Bissette United States
Marisa Roberto United States
Jessica E. Malberg United States
Angelos Halaris United States
Elisabeth Mocaër
Citations per year, relative to Elisabeth Mocaër Elisabeth Mocaër (= 1×) peers Angelos Halaris

Countries citing papers authored by Elisabeth Mocaër

Since Specialization
Citations

This map shows the geographic impact of Elisabeth Mocaër's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Elisabeth Mocaër with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Elisabeth Mocaër more than expected).

Fields of papers citing papers by Elisabeth Mocaër

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Elisabeth Mocaër. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Elisabeth Mocaër. The network helps show where Elisabeth Mocaër may publish in the future.

Co-authorship network of co-authors of Elisabeth Mocaër

This figure shows the co-authorship network connecting the top 25 collaborators of Elisabeth Mocaër. A scholar is included among the top collaborators of Elisabeth Mocaër based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Elisabeth Mocaër. Elisabeth Mocaër is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Mendez‐David, Indira, Jean‐Philippe Guilloux, Mariusz Papp, et al.. (2017). S 47445 Produces Antidepressant- and Anxiolytic-Like Effects through Neurogenesis Dependent and Independent Mechanisms. Frontiers in Pharmacology. 8. 462–462. 40 indexed citations
2.
Chenaf, Chouki, Eric Chapuy, Fabien Marchand, et al.. (2016). Agomelatine: a new opportunity to reduce neuropathic pain—preclinical evidence. Pain. 158(1). 149–160. 27 indexed citations
3.
Bothorel, Béatrice, et al.. (2013). Like melatonin, agomelatine (S20098) increases the amplitude of oscillations of two clock outputs: melatonin and temperature rhythms. Chronobiology International. 31(3). 371–381. 22 indexed citations
4.
Reagan, Lawrence P., et al.. (2012). The antidepressant agomelatine inhibits stress-mediated changes in amino acid efflux in the rat hippocampus and amygdala. Brain Research. 1466. 91–98. 35 indexed citations
5.
Dagytė, Girstautė, Paul G.M. Luiten, C. Gabriel, et al.. (2011). Chronic stress and antidepressant agomelatine induce region‐specific changes in synapsin I expression in the rat brain. Journal of Neuroscience Research. 89(10). 1646–1657. 32 indexed citations
7.
Bodinat, Christian de, Béatrice Guardiola‐Lemaître, Elisabeth Mocaër, et al.. (2010). Agomelatine, the first melatonergic antidepressant: discovery, characterization and development. Nature Reviews Drug Discovery. 9(8). 628–642. 342 indexed citations
8.
Dagytė, Girstautė, Folkert Postema, Laure Seguin, et al.. (2010). Agomelatine reverses the decrease in hippocampal cell survival induced by chronic mild stress. Behavioural Brain Research. 218(1). 121–128. 62 indexed citations
9.
Dagytė, Girstautė, Andrea Trentani, Folkert Postema, et al.. (2010). The Novel Antidepressant Agomelatine Normalizes Hippocampal Neuronal Activity and Promotes Neurogenesis in Chronically Stressed Rats. CNS Neuroscience & Therapeutics. 16(4). 195–207. 52 indexed citations
10.
Païzanis, Eleni, Thibault Renoir, Vincent Lelièvre, et al.. (2009). Behavioural and neuroplastic effects of the new-generation antidepressant agomelatine compared to fluoxetine in glucocorticoid receptor-impaired mice. The International Journal of Neuropsychopharmacology. 13(6). 759–774. 100 indexed citations
11.
Popoli, Maurizio, Laura Musazzi, V.S. Barbiero, et al.. (2008). The novel antidepressant agomelatine reduces the release of glutamate induced by acute footshock stress in synaptosomes of prefrontal/frontal cortex. BOA (University of Milano-Bicocca). 1 indexed citations
12.
Conboy, Lisa, Phillip R. Zoladz, Adam M. Campbell, et al.. (2008). The antidepressant agomelatine blocks the adverse effects of stress on memory and enables spatial learning to rapidly increase neural cell adhesion molecule (NCAM) expression in the hippocampus of rats. The International Journal of Neuropsychopharmacology. 12(3). 329–329. 56 indexed citations
13.
Legros, Céline, C. Gabriel, Elisabeth Mocaër, et al.. (2007). First evidence of melatonin receptors distribution in the suprachiasmatic nucleus of tree shrew brain.. PubMed. 28(3). 267–73. 8 indexed citations
14.
Daszuta, A., Mounira Banasr, Amélie Soumier, M. Héry, & Elisabeth Mocaër. (2005). Dépression et neuroplasticité : implication des systèmes sérotoninergiques. Therapies. 60(5). 461–468. 13 indexed citations
15.
Hanoun, Naı̈ma, Elisabeth Mocaër, Pierre‐Alain Boyer, M. Hamon, & Laurence Lanfumey. (2004). Differential effects of the novel antidepressant agomelatine (S 20098) versus fluoxetine on 5-HT1A receptors in the rat brain. Neuropharmacology. 47(4). 515–526. 60 indexed citations
16.
Beau, J Le, et al.. (2004). Circadian rhythm entrainment with melatonin, melatonin receptor antagonist S22153 or their combination in mice exposed to constant light. Journal of Pineal Research. 37(3). 176–184. 10 indexed citations
17.
Vis, Peter, Oscar Della Pasqua, Menno R. Kruk, et al.. (2001). Population pharmacokinetic–pharmacodynamic modelling of S 15535, a 5-HT1A receptor agonist, using a behavioural model in rats. European Journal of Pharmacology. 414(2-3). 233–243. 8 indexed citations
18.
Fabre, Véronique, Claudette Boni, Elisabeth Mocaër, et al.. (1997). []Alnespirone: A novel specific radioligand of 5-HT1A receptors in the rat brain. European Journal of Pharmacology. 337(2-3). 297–308. 21 indexed citations
19.
Lejeune, Helga, et al.. (1995). Amineptine, response timing, and time discrimination in the albino rat. Pharmacology Biochemistry and Behavior. 51(2-3). 165–173. 17 indexed citations
20.
Protais, Philippe, Mark Windsor, Elisabeth Mocaër, & E Comoy. (1995). Post-synaptic 5-HT1A receptor involvement in yawning and penile erections induced by apomorphine, physostigmine and mCPP in rats. Psychopharmacology. 120(4). 376–383. 23 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026